Accretion Pharmaceuticals

Accretion Pharmaceuticals Limited was founded in 2012 as a partnership firm to establish a pharmaceutical manufacturing unit, later converting to a limited company in 2023. The company's core vision is to provide healthcare products that meet global quality benchmarks while being offered at competitive prices to serve a broad market. In addition to direct sales, a major part of its business involves manufacturing pharmaceutical products for other marketing companies on a loan license or contract basis. Its diverse product portfolio includes tablets, capsules, oral liquids, and external preparations like ointments, creams, medicated shampoos, and dusting powders. To improve its global reach, the company plans to register its plant and products with international authorities to facilitate direct exports to markets worldwide. The company is certified under ISO 9001:2015, ISO 14001:2015, and ISO 22000:2018, reflecting its commitment to quality and environmental standards.;